Low Birth-weight Clinical Trial
— KMC-OromiaOfficial title:
KMC Implementation Research for Accelerating Scale-up in Oromia Region, Ethiopia
| NCT number | NCT03419416 |
| Other study ID # | 201523748 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 24, 2017 |
| Est. completion date | June 30, 2019 |
| Verified date | July 2019 |
| Source | Addis Ababa University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
The main objective is to implement Kangaroo Mother Care (KMC) at selected facilities in Addis Ababa and Oromia Regions to achieve high effective coverage in the catchment population.
| Status | Completed |
| Enrollment | 700 |
| Est. completion date | June 30, 2019 |
| Est. primary completion date | June 30, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A to 28 Days |
| Eligibility |
Inclusion Criteria: - All newborns who are less than 2000 gm born within the study facilities during the study period. Exclusion Criteria: - Newborns who are sick per predefined criteria will not be provided KMC until they have been stabilized. Criteria for delay of initiation include: critical illness including apnea, decreased respiratory rate <20 breaths per minute, grunting, cyanosis, severe chest in-drawing, convulsions, unconsciousness, and severe hypothermia <32°F. |
| Country | Name | City | State |
|---|---|---|---|
| Ethiopia | Batu Hospital | Adami Tulu | Oromia |
| Ethiopia | Tirunesh Beijing Hospital | Akaki | Addis Ababa |
| Lead Sponsor | Collaborator |
|---|---|
| Addis Ababa University | Harvard School of Public Health, World Health Organization |
Ethiopia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Effective coverage of KMC at 7 days of age. | Effective coverage will be defined as adoption of skin-to-skin care for at least 8 hours and exclusive breastfeeding in the 24 hours prior to assessment. | Seven days of age |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05087160 -
Socioeconomic Inequalities Exacerbated by Mitigation Measures to COVID-19 and Differences in Prematurity Prevalence
|